Clinical Trial Update: A Study of SER-155 to Treat Diarrhea in People on Immunotherapy [Phase 1]

View source ↗

Summary

This update describes a Phase 1 study of SER-155 for treating diarrhea and enterocolitis in patients on cancer immunotherapy, with the study currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enterocolitis

Drugs mentioned

• SER-155

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Diarrhea, Enterocolitis | Phase 1 | Status: RECRUITING